Literature DB >> 9797725

The identification of salicylates as normal constituents of serum: a link between diet and health?

J R Paterson1, C Blacklock, G Campbell, D Wiles, J R Lawrence.   

Abstract

AIM: To examine sera for the presence of salicylic acid and 2,3- and 2,5-dihydroxybenzoic acids (2,3- and 2,5-DHBA), in individuals not taking salicylate drugs.
METHODS: Extracts of acidified serum samples were analysed by high performance liquid chromatography with electro-chemical detection. The chromatographic conditions were altered, and the retention times of the unknown compounds compared against authentic salicylic acid, 2,3-DHBA, and 2,5-DHBA. Serum samples (some spiked with salicylic acid) were incubated with salicylate hydroxylase and analyses undertaken. An extract of acidified serum was derivatised using N-methyl-N-trimethylsilyltrifluoroacetamide and the salicylic acid derivative identified by gas chromatography-mass spectrometry.
RESULTS: Salicylic acid, 2,3-DHBA, and 2,5-DHBA were identified as being normal constituents of serum.
CONCLUSIONS: Salicylic acid, 2,3-DHBA, and 2,5-DHBA possess anti-inflammatory properties. The finding that these compounds are present as normal constituents of serum, possibly arising from diet, raises important questions as to their role in the promotion of health.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9797725      PMCID: PMC500801          DOI: 10.1136/jcp.51.7.502

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  19 in total

1.  2,3-Dihydroxybenzoic acid is a product of human aspirin metabolism.

Authors:  M Grootveld; B Halliwell
Journal:  Biochem Pharmacol       Date:  1988-01-15       Impact factor: 5.858

2.  Take two glasses of wine and see me in the morning.

Authors:  C J Muller; K C Fugelsang
Journal:  Lancet       Date:  1994-06-04       Impact factor: 79.321

Review 3.  Salicylate metabolism in man.

Authors:  C Davison
Journal:  Ann N Y Acad Sci       Date:  1971-07-06       Impact factor: 5.691

4.  Some characteristics of the prostaglandin synthesizing system in rabbit kidney microsomes.

Authors:  G J Blackwell; R J Flower; J R Vane
Journal:  Biochim Biophys Acta       Date:  1975-07-22

5.  Suppression of human colorectal mucosal prostaglandins: determining the lowest effective aspirin dose.

Authors:  M T Ruffin; K Krishnan; C L Rock; D Normolle; M A Vaerten; M Peters-Golden; J Crowell; G Kelloff; C R Boland; D E Brenner
Journal:  J Natl Cancer Inst       Date:  1997-08-06       Impact factor: 13.506

6.  Pharmacokinetics of aspirin and salicylate in relation to inhibition of arachidonate cyclooxygenase and antiinflammatory activity.

Authors:  G A Higgs; J A Salmon; B Henderson; J R Vane
Journal:  Proc Natl Acad Sci U S A       Date:  1987-03       Impact factor: 11.205

7.  Aspirin and the prevention of colorectal cancer: a review of the evidence.

Authors:  A Paganini-Hill
Journal:  Semin Surg Oncol       Date:  1994 May-Jun

8.  Aspirin inhibits interleukin 1-induced prostaglandin H synthase expression in cultured endothelial cells.

Authors:  K K Wu; R Sanduja; A L Tsai; B Ferhanoglu; D S Loose-Mitchell
Journal:  Proc Natl Acad Sci U S A       Date:  1991-03-15       Impact factor: 11.205

9.  Is aspirin a prodrug for antioxidant and cytokine-modulating oxymetabolites?

Authors:  D R Haynes; P F Wright; S J Gadd; M W Whitehouse; B Vernon-Roberts
Journal:  Agents Actions       Date:  1993-05

10.  Direct gradient reversed-phase high-performance liquid chromatographic determination of salicylic acid, with the corresponding glycine and glucuronide conjugates in human plasma and urine.

Authors:  T B Vree; E W van Ewijk-Beneken Kolmer; C P Verwey-van Wissen; Y A Hekster
Journal:  J Chromatogr       Date:  1994-02-11
View more
  8 in total

1.  Salicylic acid in the serum of subjects not taking aspirin. Comparison of salicylic acid concentrations in the serum of vegetarians, non-vegetarians, and patients taking low dose aspirin.

Authors:  C J Blacklock; J R Lawrence; D Wiles; E A Malcolm; I H Gibson; C J Kelly; J R Paterson
Journal:  J Clin Pathol       Date:  2001-07       Impact factor: 3.411

2.  Serum salicylate levels and risk of recurrent colorectal adenomas.

Authors:  Aasma Shaukat; Maria V Grau; Timothy R Church; Gwen Baxter; Elizabeth L Barry; Robert Summers; Robert S Sandler; John A Baron
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-02-09       Impact factor: 4.254

3.  Aspirin use and knowledge in the community: a population- and health facility based survey for measuring local health system performance.

Authors:  Gregory A Roth; Catherine W Gillespie; Ali A Mokdad; Danny D Shen; David W Fleming; Andy Stergachis; Christopher J L Murray; Ali H Mokdad
Journal:  BMC Cardiovasc Disord       Date:  2014-02-07       Impact factor: 2.298

4.  Metabolomic Profiling Identified Serum Metabolite Biomarkers and Related Metabolic Pathways of Colorectal Cancer.

Authors:  Chengjian Zhang; Shengnan Zhou; Huijing Chang; Feng Zhuang; Yang Shi; Le Chang; Wanchao Ai; Juan Du; Wei Liu; Humin Liu; Xukun Zhou; Zhong Wang; Tao Hong
Journal:  Dis Markers       Date:  2021-12-07       Impact factor: 3.434

5.  Salicylic acid sans aspirin in animals and man: persistence in fasting and biosynthesis from benzoic acid.

Authors:  John R Paterson; Gwendoline Baxter; Jacob S Dreyer; John M Halket; Robert Flynn; James R Lawrence
Journal:  J Agric Food Chem       Date:  2008-12-24       Impact factor: 5.279

Review 6.  Hydroxybenzoic acid isomers and the cardiovascular system.

Authors:  Bernhard H J Juurlink; Haya J Azouz; Alaa M Z Aldalati; Basmah M H AlTinawi; Paul Ganguly
Journal:  Nutr J       Date:  2014-06-19       Impact factor: 3.271

7.  Salicylic acid metabolites and derivatives inhibit CDK activity: Novel insights into aspirin's chemopreventive effects against colorectal cancer.

Authors:  Rakesh Dachineni; D Ramesh Kumar; Eduardo Callegari; Siddharth S Kesharwani; Ranjini Sankaranarayanan; Teresa Seefeldt; Hemachand Tummala; G Jayarama Bhat
Journal:  Int J Oncol       Date:  2017-10-19       Impact factor: 5.650

Review 8.  Do Aspirin and Flavonoids Prevent Cancer through a Common Mechanism Involving Hydroxybenzoic Acids?-The Metabolite Hypothesis.

Authors:  Ranjini Sankaranarayanan; D Ramesh Kumar; Janki Patel; G Jayarama Bhat
Journal:  Molecules       Date:  2020-05-10       Impact factor: 4.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.